Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real‐World Clinical Setting

BACKGROUND. Regorafenib improved the overall survival (OS) of patients with metastatic colorectal cancer (mCRC) who progress after standard therapies in two phase III trials. The present large‐scale prospective observational study evaluated the safety and effectiveness of regorafenib administered to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Yamaguchi, Kensei, Komatsu, Yoshito, Satoh, Taroh, Uetake, Hiroyuki, Yoshino, Takayuki, Nishida, Toshirou, Yamazaki, Naoya, Takikawa, Hajime, Morimoto, Takashi, Chosa, Masayuki, Sunaya, Toshiyuki, Hamada, Yoko, Muro, Kei, Sugihara, Kenichi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656456/
https://ncbi.nlm.nih.gov/pubmed/30606885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0377
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados